Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts FENC Hot Sheet
Join SI Premium – FREE
Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.65 million versus the consensus estimate of $9.39 million.
For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ericsson (ERIC) Tops Q2 EPS by 3c
- JPMorgan Downgrades Pearson PLC (PSON:LN) (PSO) to Neutral
- Morgan Stanley Starts Gjensidige Forsikring ASA (GJF:NO) (GJNSY) at Underweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
